Upper airway anesthesia induces airflow limitation in awake humans.

PubWeight™: 0.89‹?›

🔗 View Article (PMID 1519832)

Published in Am Rev Respir Dis on September 01, 1992

Authors

G Liistro1, D C Stănescu, C Veriter, D O Rodenstein, J P D'Odemont

Author Affiliations

1: Pulmonary Laboratory, Cliniques Universitaires Saint-Luc, Brussels, Belgium.

Articles by these authors

Tracheobronchial foreign bodies: presentation and management in children and adults. Chest (1999) 5.93

Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils. Thorax (1996) 2.52

Identification of smokers susceptible to development of chronic airflow limitation: a 13-year follow-up. Chest (1998) 1.73

Microsleep during a simplified maintenance of wakefulness test. A validation study of the OSLER test. Am J Respir Crit Care Med (2001) 1.57

Residual effect of nCPAP applied for part of the night in patients with obstructive sleep apnoea. Eur Respir J (1997) 1.49

Diurnal and nocturnal diuresis and natriuresis in obstructive sleep apnea. Effects of nasal continuous positive airway pressure therapy. Am Rev Respir Dis (1992) 1.47

Management of simple snoring in adults. Monaldi Arch Chest Dis (1993) 1.42

In long-term smokers and former smokers the bronchodilator response is not related to the fall in FEV. Respiration (2000) 1.40

Treatment of relapse of small cell lung cancer in selected patients with the initial combination chemotherapy carboplatin, etoposide, and epirubicin. Thorax (1992) 1.40

Iatrogenic tracheobronchial lacerations. Ann Thorac Surg (1997) 1.38

Reassessment of lung volume measurement by helium dilution and by body plethysmography in chronic air-flow obstruction. Am Rev Respir Dis (1982) 1.37

Failure of body plethysmography in bronchial asthma. J Appl Physiol Respir Environ Exerc Physiol (1982) 1.26

High Mallampati score and nasal obstruction are associated risk factors for obstructive sleep apnoea. Eur Respir J (2003) 1.19

Improvement of global and regional left ventricular function in patients with previous myocardial infarction by a new beta 1 adrenoceptor partial agonist, ICI 118,587. Eur Heart J (1982) 1.16

Nasal continuous positive airway pressure in the perioperative management of patients with obstructive sleep apnea submitted to surgery. Chest (1995) 1.16

Demonstration of failure of body plethysmography in airway obstruction. J Appl Physiol Respir Environ Exerc Physiol (1982) 1.15

Respiratory failure due to tracheobronchomalacia. Thorax (1996) 1.14

Impaired early left ventricular relaxation in coronary artery disease: effects of intracornary nifedipine. Circulation (1980) 1.12

Compliance with nasal CPAP in obstructive sleep apnea patients. Sleep Med Rev (1997) 1.09

Ambulatory evaluation of sleep disturbance and therapeutic effects in sleep apnea syndrome by wrist activity monitoring. Am Rev Respir Dis (1987) 1.09

Acceptance and long-term compliance with nCPAP in patients with obstructive sleep apnoea syndrome. Eur Respir J (1996) 1.07

Emotional laryngeal wheezing: a new syndrome. Am Rev Respir Dis (1983) 1.06

Glottis opening and airway resistance. J Appl Physiol (1972) 1.06

Soft palate and oronasal breathing in humans. J Appl Physiol Respir Environ Exerc Physiol (1984) 1.04

Smoking, lung function, and body weight. Br Med J (Clin Res Ed) (1983) 1.04

Normal pregnancy in primary alveolar hypoventilation treated with nocturnal nasal intermittent positive pressure ventilation. Eur Respir J (1995) 1.03

Impairment of ventilatory function and pulmonary gas exchange in non-smoking coalminers. Lancet (1987) 1.00

Failure of tonsil and nose surgery in adults with long-standing severe sleep apnea syndrome. Arch Intern Med (1989) 0.99

Expiratory flow limitation in awake sleep-disordered breathing subjects. Eur Respir J (1999) 0.98

Noninvasive ventilation for acute respiratory failure: a prospective randomised placebo-controlled trial. Eur Respir J (2002) 0.96

Mouth spraying versus inhalation of fenoterol aerosol in healthy subjects and asthmatic patients. Br J Dis Chest (1982) 0.95

Significance of small airway tests in middle-aged smokers. Am Rev Respir Dis (1981) 0.95

Smoking and pulmonary diffusing capacity. Scand J Respir Dis (1975) 0.94

Changes in lung function after smoking cessation: an assessment from a cross-sectional survey. Am Rev Respir Dis (1982) 0.93

Expiratory flow limitation during sleep in heavy snorers and obstructive sleep apnoea patients. Eur Respir J (1996) 0.93

Lung diffusing capacity. Normal values in male smokers and non-smokers using the breath-holding technique. Scand J Respir Dis (1970) 0.92

Effects of nasal positive-pressure hyperventilation on the glottis in normal sleeping subjects. J Appl Physiol (1985) (1995) 0.92

Spontaneous favorable outcome of tracheal laceration. Chest (1991) 0.92

Frequency dependence of plethysmographic volume in healthy and asthmatic subjects. J Appl Physiol Respir Environ Exerc Physiol (1983) 0.91

Effects on lung of chronic occupational exposure to cadmium. Scand J Respir Dis (1977) 0.90

Weight loss as a treatment for obstructive sleep apnoea. Sleep Med Rev (2000) 0.90

Pattern of snoring in obstructive sleep apnea patients and in heavy snorers. Sleep (1991) 0.90

"Sensitive tests" are poor predictors of the decline in forced expiratory volume in one second in middle-aged smokers. Am Rev Respir Dis (1987) 0.89

Reassessment of the interruption technique for measuring flow resistance in humans. J Appl Physiol (1985) (1989) 0.89

Pattern of breathing and ventilatory response to CO2 in subjects practicing hatha-yoga. J Appl Physiol Respir Environ Exerc Physiol (1981) 0.89

Bronchial asthma following exposure to ECG ink. Ann Allergy (1982) 0.89

The soft palate and breathing. Am Rev Respir Dis (1986) 0.88

Head position modifies upper airway resistance in men. J Appl Physiol (1985) (1988) 0.88

Pulmonary diffusing capacity for carbon monoxide in simple coal workers' pneumoconiosis. Bull Physiopathol Respir (Nancy) (1976) 0.86

Reevaluation of the radiographic method for measurement of total lung capacity. Bull Eur Physiopathol Respir (1986) 0.86

Infants are not obligatory nasal breathers. Am Rev Respir Dis (1985) 0.86

Lung function measurements over 21 days shiftwork in steelworkers from a strandcasting department. Br J Ind Med (1985) 0.86

Pattern of inhalation of tobacco smoke in pipe, cigarette, and never smokers. Am Rev Respir Dis (1985) 0.86

Effects of nasal positive-pressure hyperventilation on the glottis in normal awake subjects. J Appl Physiol (1985) (1995) 0.84

Bronchial asthma without increased airway reactivity. Eur J Respir Dis (1982) 0.84

Continuous positive airway pressure treatment for sleep apnoea: compliance increases with time in continuing users. Eur Respir J (2006) 0.84

Ventilatory and diaphragmatic EMG responses to negative-pressure ventilation in airflow obstruction. J Appl Physiol (1985) (1988) 0.84

Effect of alveolar volume on the interpretation of single breath DLCO. Respir Med (1997) 0.83

Pulmonary function in workers with chronic exposure to cadmium oxide fumes. Int Arch Arbeitsmed (1970) 0.83

Influence of the respiratory route on the resting breathing pattern in humans. Am Rev Respir Dis (1985) 0.83

Nasal occlusion during sleep in normal and near-miss for sudden death syndrome infants. Bull Eur Physiopathol Respir (1987) 0.83

Airway closure in humans does not result in overestimation of plethysmographic lung volume. J Appl Physiol Respir Environ Exerc Physiol (1983) 0.83

Pattern of simulated snoring is different through mouth and nose. J Appl Physiol (1985) (1991) 0.82

Pulmonary function in status asthmaticus: effect of therapy. Thorax (1970) 0.82

Bronchodilator effect of inhaled nitric oxide in healthy men. Am J Respir Crit Care Med (1994) 0.82

Frequency dependence of respiratory resistance in healthy children. J Appl Physiol Respir Environ Exerc Physiol (1979) 0.82

Maximum respiratory pressures in trumpet players. Chest (1993) 0.81

Hemodynamic and cardiac effects of nicardipine in patients with coronary artery disease. J Cardiovasc Pharmacol (1984) 0.81

Cure of sleep apnea syndrome after long-term nasal continuous positive airway pressure therapy and weight loss. Sleep (1989) 0.81

Comparison of lung deposition of amikacin by intrapulmonary percussive ventilation and jet nebulization by urinary monitoring. J Aerosol Med (2006) 0.81

Determinants of Fi,O2 with oxygen supplementation during noninvasive two-level positive pressure ventilation. Eur Respir J (2002) 0.81

Movement arousals and sleep-related disordered breathing in adults. Am J Respir Crit Care Med (1996) 0.80

Absence of nasal air flow during pursed lips breathing. The soft palate mechanisms. Am Rev Respir Dis (1983) 0.80

Effects of Breathe Right on snoring: a polysomnographic study. Respir Med (1998) 0.80

Effects of two inotropic drugs, dopamine and dobutamine, on pulmonary gas exchange in artificially ventilated patients. Intensive Care Med (1989) 0.80

Upper airway obstruction during nasal intermittent positive-pressure hyperventilation in sleep. Lancet (1991) 0.80

Lung function study and diffusion capacity in anorexia nervosa. J Intern Med (2000) 0.80

Inflection point on transpulmonary pressure-volume curves and closing volume. J Appl Physiol (1975) 0.80

Lung function in chronic uraemia before and after removal of excess of fluid by haemodialysis. Clin Sci Mol Med (1974) 0.79

Glottis opening and effort-dependent part of the isovolume pressure-flow curves. J Appl Physiol (1973) 0.79

Upper airway obstruction induced by negative-pressure ventilation in awake healthy subjects. J Appl Physiol (1985) (1993) 0.79

Maximal inspiratory flow rates in patients with COPD. Chest (2000) 0.79